💥 Gate Square Event: #PostToWinFLK 💥
Post original content on Gate Square related to FLK, the HODLer Airdrop, or Launchpool, and get a chance to share 200 FLK rewards!
📅 Event Period: Oct 15, 2025, 10:00 – Oct 24, 2025, 16:00 UTC
📌 Related Campaigns:
HODLer Airdrop 👉 https://www.gate.com/announcements/article/47573
Launchpool 👉 https://www.gate.com/announcements/article/47592
FLK Campaign Collection 👉 https://www.gate.com/announcements/article/47586
📌 How to Participate:
1️⃣ Post original content related to FLK or one of the above campaigns (HODLer Airdrop / Launchpool).
2️⃣ Content mu
Tianjin Novartis has reached an authorized protocol with Sanofi, with a potential total price of up to 200 million euros.
Jinshi data news on September 25th, on September 25th, Tianjing Biotechnology announced that it has reached a strategic cooperation with Sanofi on the development, production, and commercialization of its independently developed global innovative CD73 monoclonal antibody Ureliumab in the Greater China region. Sanofi will pay Tianjing Biotechnology approximately 32 million euros in initial payment and near-term milestone payments, as well as specific registration and sales milestone payments; the potential total consideration will not exceed 213 million euros.